Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 10150297

Recognizing and treating depression.

E S Geringer·C Wool
View original source ↗Export metadata ↓

Abstract

The increasing number of antidepressant agents available presents the problem of selecting the right one for a given patient. The choice is guided by the benefits and risks of these drugs within the context of the recommended treatment strategy.

Explore related subjects

Antidepressive AgentsDepressive DisorderDiagnosis, DifferentialHumansJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E S Geringer, C Wool. 1994. Recognizing and treating depression.. https://pubmed.ncbi.nlm.nih.gov/10150297/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Neurotropic and psychotropic drugs in dermatology.

Several psychotropic and neurotropic agents are useful in treating patients with skin diseases such as obsessive compulsive skin manipulation, delusions of parasitosis, generalized pruritus, and post-herpetic neuralgia. The mechanism of action of these agents is based on their interaction with central and peripheral neuronal receptors. The medications discussed in this article include the tricyclic antidepressants, serotonin reuptake inhibitors, naltrexone, pimozide, and gabapentin. The pharmacology, mechanism of action, adverse effects, drug interactions, and monitoring guidelines are outlined for each of these drugs.

Antidepressive Agents↗
PubMed2001

The secretion of parotid saliva as stimulated by 10% citric acid is not related to precipitating factors in burning mouth syndrome.

Burning mouth syndrome (BMS) is known to have multiple precipitating factors and exists in various clinical subtypes. If salivary gland function was compromised in BMS it could help explain the link with diverse precipitating factors. This study quantified stimulated right and left parotid flow rates (SPFR) in 114 patients with BMS. It also attempted to correlate SPFR with haematinic parameters, oral candidal carriage, concurrent drug therapy and BMS subtype. No relationship was found between haematinic parameters and SPFR nor between SPFR and oral candidal carriage. Patients with Type 2 BMS had a significant reduction in SPFR. Antidepressant medication was associated with reduced SPFR but there was no such association with either tranquillisers or hypnotics. These results provide evidence of reduced parotid gland function in Type 2 BMS and a role for antidepressant medication in reducing SPFR.

Antidepressive Agents↗